Redwood Pharma AB
0
0
+SEK0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Redwood Pharma AB engages in the development of ophthalmic drugs for medical needs in Sweden. Its lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women; and RP501, a next generation smart hydrogel medical device for the treatment of mild dry eye. The company was founded in 2012 and is headquartered in Stockholm, Sweden.
Show More
CEO
Mr. Ulf Bjorklund M.Sc.
Employees
1
Country
Sweden
ISIN
SE0022060778
Listings
0 Comments
Share your thoughts
FAQs
What is Redwood Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Redwood Pharma AB stocks are traded under the ticker REDW-BT-UN.ST.
How many employees does Redwood Pharma AB have?▼
As of November 4, 2026, the company has 1 employees.
In which sector is Redwood Pharma AB located?▼
Redwood Pharma AB operates in the Health & Wellness sector.
When did Redwood Pharma AB complete a stock split?▼
Redwood Pharma AB has not had any recent stock splits.
Where is Redwood Pharma AB headquartered?▼
Redwood Pharma AB is headquartered in Stockholm, Sweden.